Cannabidiol, or CBD for short, is a cannabis ingredient that is widely utilized for medical purposes. The substance, which was formerly classified as federally banned prior to the passing of the 2018 Farm Bill, is used to treat anxiety, dystonia, and Parkinson’s disease, among other medical ailments. The global market grew by 26.42 percent in 2020, which was much less than the average year-on-year growth from 2017 to 2019. According to Leafly, legal cannabis sales in the United States surged by 35% to $24.6 billion in 2021.
Insider Monkey chose stocks based on their performance in the CBD industry. Village Farms International, Inc. is a marketer of agricultural products grown in greenhouses. Pure Sunfarms, the company’s wholly-owned Canadian subsidiary, is one of the world’s largest cannabis enterprises. Sundial Growers Inc. is a Canadian firm that produces, distributes, and sells cannabis and CBD products. Top Leaf, Sundial Cannabis, Palmetto, and Grasslands are among the company’s portfolio names. Aurora Cannabis Inc. is a licensed cannabis producer in Canada with headquarters in Edmonton. In March, the company paid $38 million for TerraFarma, a vertically integrated cannabis company. Cantor Fitzgerald maintained a Neutral rating on Aurora Cannabis shares with a C$3.90 price objective earlier this month. Cronos Group Inc. is a cannabis firm that focuses on medicinal marijuana and adult-use cannabis. After reporting earnings for the first three months of 2022, the global cannabis company’s stock soared 13.5 percent. Cara Treatments, Inc. is a biopharmaceutical business focused on discovering and commercializing drugs and therapeutics to treat pain and inflammation-related disorders. The company is also working on cannabinoid receptor agonists that can be taken orally. For more details, click 10 Best CBD Stocks To Invest In.
